ESMO Asia 2016 Congress

Central Nervous System Malignancies

16 Dec - 19 Dec 2016, Singapore

ESMO Asia 2016 Square

The ESMO Asia Congress comprised both scientific and educational tracks prepared by an international scientific committee. There was a strong emphasis on state of the art science, including a call for abstracts, and the current standard of care across all major tumour types.

Abstracts, presentations and webcasts from the ESMO Asia 2016 Congress are now available here to ESMO members. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links





Format available

Management of toxicities

https://oncologypro.esmo.org/Meeting-Resour...-Asia-2016-Congress/Management-of-toxicities

Date: 16 Dec 2016
Presenter: Matti Aapro
Resources: Webcast

What is different in lung cancer patients?

https://oncologypro.esmo.org/Meeting-Resour...ss/What-is-different-in-lung-cancer-patients

Date: 16 Dec 2016
Presenter: Yi-Long Wu
Resources: Presentation, Webcast

Introduction: The problems of skeletal-related events in malignancies

https://oncologypro.esmo.org/Meeting-Resour...s-of-skeletal-related-events-in-malignancies

Date: 16 Dec 2016
Presenter: Matti Aapro
Resources: Presentation, Webcast

Mechanisms and actions to prevent skeletal-related events

https://oncologypro.esmo.org/Meeting-Resour...d-actions-to-prevent-skeletal-related-events

Date: 16 Dec 2016
Presenter: Christoph Zielinski
Resources: Presentation, Webcast

Mechanisms of bone loss and burden of fracture in (young) breast cancer patients receiving cancer therapy

https://oncologypro.esmo.org/Meeting-Resour...ast-cancer-patients-receiving-cancer-therapy

Date: 16 Dec 2016
Presenter: Alexandru Eniu
Resources: Presentation, Webcast

Specific issues for (older) male patients under treatment for prostate cancer

https://oncologypro.esmo.org/Meeting-Resour...patients-under-treatment-for-prostate-cancer

Date: 16 Dec 2016
Presenter: Alvin Wong
Resources: Presentation, Webcast

Guidelines including grading of novel drugs with ESMO-MCBS

https://oncologypro.esmo.org/Meeting-Resour...luding-grading-of-novel-drugs-with-ESMO-MCBS

Date: 16 Dec 2016
Presenter: George Pentheroudakis
Resources: Presentation, Webcast
Topic: Anticancer Agents

The clinical significance of deregulated cyclin E1 in high grade serous ovarian cancer (HGSOC)

https://oncologypro.esmo.org/Meeting-Resour...E1-in-high-grade-serous-ovarian-cancer-HGSOC

BackgroundCyclin E1 protein is highly expressed in 30% of HGSOC, and while CCNE1 amplification provides a plausible mechanism in about half of cases, the driver and the clinical impact of high expression...

Date: 16 Dec 2016
Presenter: Diar Aziz
Resources: Abstract
Topics: Ovarian Cancer, Translational Research

Genomic Signature identifying origins of EOC from Fallopian tube and ovary epithelium

https://oncologypro.esmo.org/Meeting-Resour...EOC-from-Fallopian-tube-and-ovary-epithelium

BackgroundThe molecular mechanism of epithelial ovarian cancer (EOC) is poorly understood. As a result, the treatment and overall survival of EOC have improved little for decades.

Date: 16 Dec 2016
Presenter: Li-jun Di
Resources: Abstract
Topics: Ovarian Cancer, Translational Research

Invited Discussant 297O, 298O and 299O

https://oncologypro.esmo.org/Meeting-Resour...ngress/Invited-Discussant-297O-298O-and-299O

Date: 16 Dec 2016
Presenter: Cristiana Sessa
Resources: Presentation, Webcast
Topics: Ovarian Cancer, Translational Research